操作建议
Tempus AI Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名88/404位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价91.79。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Tempus AI Inc简介
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
公司代码TEM
公司Tempus AI Inc
CEOLefkofsky (Eric P)
网址https://investors.tempus.com/
常见问题
Tempus AI Inc(TEM)的当前股价是多少?
Tempus AI Inc(TEM)的当前股价是 69.409。
Tempus AI Inc股票的52周最高点是多少?
Tempus AI Inc股票的52周最高点是104.320。
Tempus AI Inc股票的52周最低点是多少?
Tempus AI Inc股票的52周最低点是31.360。
Tempus AI Inc的净利润为-746.33M。
现在Tempus AI Inc(TEM)的股票是买入、持有还是卖出?
根据分析师评级,Tempus AI Inc(TEM)的总体评级为买入,目标价格为91.785。
Tempus AI Inc(TEM)股票的每股收益(EPS TTM)是多少
Tempus AI Inc(TEM)股票的每股收益(EPS TTM)是-0.291。